The most common side effects mirror those of injectable GLP-1s nausea, mild digestive discomfort, reduced appetite, and occasional headaches, particularly in the first few weeks
They also act on the appetite centers in the brain, significantly reducing hunger and what is often called food noise. The dual-action drug tirzepatide works on both GLP-1 and GIP receptors, often leading to even greater efficacy
The company frames its pricing against expensive GLP-1 drugs, which can cost $1,000 or more per month
Contraindication clarity: Whether the company clearly states who should not use the product
Data reflects an independent analysis conducted by Inovalon for illustrative purposes only and was not funded by any external sponsor
Tirzepatide is very similar to Semaglutide